1437 related articles for article (PubMed ID: 15642142)
1. The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin.
Giles I; Lambrianides N; Latchman D; Chen P; Chukwuocha R; Isenberg D; Rahman A
Arthritis Res Ther; 2005; 7(1):R47-56. PubMed ID: 15642142
[TBL] [Abstract][Full Text] [Related]
2. Arginine mutation alters binding of a human monoclonal antibody to antigens linked to systemic lupus erythematosus and the antiphospholipid syndrome.
Lambrianides A; Giles I; Ioannou Y; Mason L; Latchman DS; Manson JJ; Isenberg DA; Rahman A
Arthritis Rheum; 2007 Jul; 56(7):2392-401. PubMed ID: 17599767
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies, lupus and the science of sabotage.
Rahman A
Rheumatology (Oxford); 2004 Nov; 43(11):1326-36. PubMed ID: 15328419
[TBL] [Abstract][Full Text] [Related]
4. Cardiolipin binding a light chain from lupus-prone mice.
Pereira B; Benedict CR; Le A; Shapiro SS; Thiagarajan P
Biochemistry; 1998 Feb; 37(5):1430-7. PubMed ID: 9477972
[TBL] [Abstract][Full Text] [Related]
5. Relative importance of different human aPL derived heavy and light chains in the binding of aPL to cardiolipin.
Giles IP; Haley J; Nagl S; Latchman DS; Chen PP; Chukwuocha RU; Isenberg DA; Rahman A
Mol Immunol; 2003 Sep; 40(1):49-60. PubMed ID: 12909130
[TBL] [Abstract][Full Text] [Related]
6. Arginine residues are important in determining the binding of human monoclonal antiphospholipid antibodies to clinically relevant antigens.
Giles I; Lambrianides N; Pattni N; Faulkes D; Latchman D; Chen P; Pierangeli S; Isenberg D; Rahman A
J Immunol; 2006 Aug; 177(3):1729-36. PubMed ID: 16849482
[TBL] [Abstract][Full Text] [Related]
7. Building novel binding ligands to B7.1 and B7.2 based on human antibody single variable light chain domains.
van den Beucken T; van Neer N; Sablon E; Desmet J; Celis L; Hoogenboom HR; Hufton SE
J Mol Biol; 2001 Jul; 310(3):591-601. PubMed ID: 11439026
[TBL] [Abstract][Full Text] [Related]
8. Properties of whole human IgG molecules produced by the expression of cloned anti-DNA antibody cDNA in mammalian cells.
Rahman MA; Kettleborough CA; Latchman DS; Isenberg DA
J Autoimmun; 1998 Dec; 11(6):661-9. PubMed ID: 9878088
[TBL] [Abstract][Full Text] [Related]
9. Critical binding site amino acids of anti-Z-DNA single chain Fv molecules. Role of heavy and light chain CDR3 and relationship to autoantibody activity.
Polymenis M; Stollar BD
J Immunol; 1994 Jun; 152(11):5318-29. PubMed ID: 8189049
[TBL] [Abstract][Full Text] [Related]
10. DNA binding by the VH domain of anti-Z-DNA antibody and its modulation by association of the VL domain.
Chen Y; Stollar BD
J Immunol; 1999 Apr; 162(8):4663-70. PubMed ID: 10202006
[TBL] [Abstract][Full Text] [Related]
11. Display of somatostatin-related peptides in the complementarity determining regions of an antibody light chain.
Simon PJ; Brogle KC; Wang B; Kyle DJ; Soltis DA
Arch Biochem Biophys; 2005 Aug; 440(2):148-57. PubMed ID: 16051181
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies from NZW x BXSB F1 mice to beta2 glycoprotein I and cardiolipin. Species specificity and charge-dependent binding.
Monestier M; Kandiah DA; Kouts S; Novick KE; Ong GL; Radic MZ; Krilis SA
J Immunol; 1996 Apr; 156(7):2631-41. PubMed ID: 8786329
[TBL] [Abstract][Full Text] [Related]
13. The importance of somatic mutations in the V(lambda) gene 2a2 in human monoclonal anti-DNA antibodies.
Rahman A; Haley J; Radway-Bright E; Nagl S; Low DG; Latchman DS; Isenberg DA
J Mol Biol; 2001 Mar; 307(1):149-60. PubMed ID: 11243810
[TBL] [Abstract][Full Text] [Related]
14. Analysis of BR96 binding sites for antigen and anti-idiotype by codon-based scanning mutagenesis.
Rosok MJ; Eghtedarzadeh-Kondri M; Young K; Bajorath J; Glaser S; Yelton D
J Immunol; 1998 Mar; 160(5):2353-9. PubMed ID: 9498776
[TBL] [Abstract][Full Text] [Related]
15. Generation and characterization of three monoclonal IgM antiphospholipid antibodies recognizing different phospholipid antigens.
Buschmann C; Fischer C; Ochsenhirt V; Neukirch C; Lackner KJ; von Landenberg P
Ann N Y Acad Sci; 2005 Jun; 1051():240-54. PubMed ID: 16126965
[TBL] [Abstract][Full Text] [Related]
16. Utilization of the VH4-21 gene segment by anti-DNA antibodies from patients with systemic lupus erythematosus.
Stevenson FK; Longhurst C; Chapman CJ; Ehrenstein M; Spellerberg MB; Hamblin TJ; Ravirajan CT; Latchman D; Isenberg D
J Autoimmun; 1993 Dec; 6(6):809-25. PubMed ID: 8155258
[TBL] [Abstract][Full Text] [Related]
17. Identical V region amino acid sequences and segments of sequences in antibodies of different specificities. Relative contributions of VH and VL genes, minigenes, and complementarity-determining regions to binding of antibody-combining sites.
Kabat EA; Wu TT
J Immunol; 1991 Sep; 147(5):1709-19. PubMed ID: 1908882
[TBL] [Abstract][Full Text] [Related]
18. Framework residues 71 and 93 of the chimeric B72.3 antibody are major determinants of the conformation of heavy-chain hypervariable loops.
Xiang J; Sha Y; Jia Z; Prasad L; Delbaere LT
J Mol Biol; 1995 Oct; 253(3):385-90. PubMed ID: 7473721
[TBL] [Abstract][Full Text] [Related]
19. Domain interactions and antigen binding of recombinant anti-Z-DNA antibody variable domains. The role of heavy and light chains measured by surface plasmon resonance.
Polymenis M; Stollar BD
J Immunol; 1995 Mar; 154(5):2198-208. PubMed ID: 7868893
[TBL] [Abstract][Full Text] [Related]
20. Use of human germline genes in a CDR homology-based approach to antibody humanization.
Hwang WY; Almagro JC; Buss TN; Tan P; Foote J
Methods; 2005 May; 36(1):35-42. PubMed ID: 15848073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
